TMC Life Sciences Berhad reported unaudited consolidated earnings results for the second quarter and six months ended November 30, 2015. For the quarter, the company reported revenue of MYR 31,332,000 against MYR 25,101,000 a year ago. Profit from operations was MYR 5,408,000 against MYR 3,895,000 a year ago. Profit before taxation was MYR 4,883,000 against MYR 2,121,000 a year ago. Profit attributable to owners of the parent was MYR 3,338,000 or 0.19 sen per basic and diluted share against MYR 2,307,000 or 0.20 sen per diluted share a year ago. Revenue increased by 25% compared to the previous corresponding quarter. Higher revenue was contributed by higher patient load supported by expanded bed capacity and additional consultants recruited. Profitability improved due to higher revenue recorded and interest income earned.

For the six months, the company reported revenue of MYR 61,406,000 against MYR 48,273,000 a year ago. Profit from operations was MYR 10,202,000 against MYR 6,284,000 a year ago. Profit before taxation was MYR 9,233,000 against MYR 2,765,000 a year ago. Profit attributable to owners of the parent was MYR 6,232,000 or 0.35 sen per basic and diluted share against MYR 3,035,000 or 0.26 sen per diluted share a year ago. Net cash flows from operating activities were MYR 16,250,000 against MYR 8,902,000 a year ago. Acquisition of property plant and equipment was MYR 10,994,000 against MYR 5,873,000 a year ago. The group recorded 27% growth in revenue for the 6 months ended 30 November 2015 compared with the corresponding period in the previous financial year. The growth was contributed by additional bed capacity and more variety of services offered coupled with continuing marketing activities.